Company Performance: Samsung Biologics' financial health, including revenue, profits, and debt levels, directly influences investor confidence and stock price.

Market Sentiment: Overall market optimism or pessimism impacts all stocks. Positive market trends often lift prices, while negative ones depress them.

Industry Trends: Developments within the biopharmaceutical sector, such as new drug approvals or regulatory changes, can affect Samsung Biologics' valuation.

Competitor Activities: Actions by rival companies, including new product launches or mergers, can impact Samsung Biologics' market share and stock price.

Regulatory Environment: Changes in healthcare regulations, both in South Korea and globally, can significantly affect the profitability and outlook of the company.

Global Economy: Macroeconomic factors like interest rates, inflation, and economic growth influence investment decisions and stock valuations worldwide.

News and Events: Significant news announcements, such as clinical trial results or major contracts, can cause rapid price fluctuations.

Investor Confidence: Investor belief in the company's future prospects and management's ability to execute strategy plays a crucial role.

Currency Fluctuations: Changes in the value of the Korean Won relative to other currencies can impact the company's earnings when translated.

Dividend Policy: The company's dividend payments can attract or deter investors, affecting stock demand and price.